vTv Therapeutics (VTVT) Non-Current Assets (2014 - 2026)

vTv Therapeutics has disclosed Non-Current Assets across 13 years of filings, most recently posting $4000.0 for Q2 2026.

• In Q2 2026, Non-Current Assets fell 94.59% year-over-year to $4000.0; the TTM figure through Jun 2026 stood at $53000.0 (down 90.26% YoY), while the FY2025 annual figure was $6000.0, down 96.08% from the prior year.
• Non-Current Assets came in at $4000.0 for Q2 2026 at vTv Therapeutics, down from $5000.0 in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $8.5 million in Q2 2023 to a low of $4000.0 in Q2 2026.
• Average Non-Current Assets over 5 years is $2.7 million, with a median of $284500.0 recorded in 2024.
• Year-over-year, Non-Current Assets surged 33.04% in 2023 and tumbled 96.96% in 2024.
• Over 5 years, Non-Current Assets stood at $6.1 million in 2022, then slumped by 94.12% to $361000.0 in 2023, then slumped by 57.62% to $153000.0 in 2024, then sank by 96.08% to $6000.0 in 2025, then slumped by 33.33% to $4000.0 in 2026.
• Per Business Quant data, the three most recent Non-Current Assets figures were $4000.0 in Q2 2026, $5000.0 in Q1 2026, and $6000.0 in Q4 2025.